TR200000135T2 - Tiazolidinedion ve sülfonilüre ile diabet tedavisi. - Google Patents
Tiazolidinedion ve sülfonilüre ile diabet tedavisi.Info
- Publication number
- TR200000135T2 TR200000135T2 TR2000/00135T TR200000135T TR200000135T2 TR 200000135 T2 TR200000135 T2 TR 200000135T2 TR 2000/00135 T TR2000/00135 T TR 2000/00135T TR 200000135 T TR200000135 T TR 200000135T TR 200000135 T2 TR200000135 T2 TR 200000135T2
- Authority
- TR
- Turkey
- Prior art keywords
- thiazolidinedione
- sulfonylurea
- diabetes treatment
- mammal
- mellitus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Etkili, toksik olmayan ve eczacilik teknolojisi bakimindan kabul edilebilir tutarda bir ensülin yönünden duyarli duruma getiricinin, maksimum altinda miktarda bir insülin salgilattiricisinin, bunlara gereksinmesi bulunan bir memeliye verilmesini içeren diabetas mellitus' un memelide diabetes mellitus ile iliskili durumlarin tedavi edilmeleri için yöntem ile bu gibi yöntemin kullanilmasina yarar bilesim.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9715306A GB9715306D0 (en) | 1997-07-18 | 1997-07-18 | Novel method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200000135T2 true TR200000135T2 (tr) | 2000-05-22 |
Family
ID=10816177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/00135T TR200000135T2 (tr) | 1997-07-18 | 1998-07-16 | Tiazolidinedion ve sülfonilüre ile diabet tedavisi. |
Country Status (41)
Country | Link |
---|---|
EP (1) | EP0998291B2 (tr) |
JP (2) | JP2001510158A (tr) |
KR (1) | KR100680667B1 (tr) |
CN (1) | CN1264302A (tr) |
AP (1) | AP1318A (tr) |
AR (2) | AR016768A1 (tr) |
AT (1) | ATE366577T1 (tr) |
AU (1) | AU743269B2 (tr) |
BG (1) | BG64892B1 (tr) |
BR (1) | BR9810904A (tr) |
CA (1) | CA2297115C (tr) |
CO (1) | CO4940422A1 (tr) |
CY (1) | CY1107745T1 (tr) |
CZ (1) | CZ302668B6 (tr) |
DE (1) | DE69838066T3 (tr) |
DK (1) | DK0998291T4 (tr) |
DZ (1) | DZ2564A1 (tr) |
EA (1) | EA003303B1 (tr) |
ES (1) | ES2290989T5 (tr) |
GB (1) | GB9715306D0 (tr) |
HK (1) | HK1029272A1 (tr) |
HU (1) | HU229119B1 (tr) |
ID (1) | ID24198A (tr) |
IL (1) | IL134045A0 (tr) |
IN (1) | IN189035B (tr) |
MA (1) | MA26522A1 (tr) |
MY (1) | MY138246A (tr) |
NO (1) | NO326356B1 (tr) |
NZ (3) | NZ520652A (tr) |
OA (1) | OA11632A (tr) |
PE (1) | PE99799A1 (tr) |
PL (2) | PL199125B1 (tr) |
PT (1) | PT998291E (tr) |
SI (1) | SI0998291T2 (tr) |
SK (2) | SK287823B6 (tr) |
TR (1) | TR200000135T2 (tr) |
TW (1) | TW586926B (tr) |
UA (1) | UA70302C2 (tr) |
UY (1) | UY25103A1 (tr) |
WO (1) | WO1999003476A1 (tr) |
ZA (1) | ZA986365B (tr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1832291A3 (en) * | 1999-07-13 | 2009-11-04 | Medicure Inc. | use of pyridoxal phosphate for the treatment of diabetes and related complications |
EP1897547A1 (en) * | 1999-07-13 | 2008-03-12 | Medicure Inc. | Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications |
US6586438B2 (en) | 1999-11-03 | 2003-07-01 | Bristol-Myers Squibb Co. | Antidiabetic formulation and method |
US20010036479A1 (en) | 2000-01-14 | 2001-11-01 | Gillian Cave | Glyburide composition |
CA2434169C (en) | 2001-01-12 | 2011-03-15 | Sun Pharmaceutical Industries Limited | Spaced drug delivery system |
WO2005041962A1 (en) | 2003-10-31 | 2005-05-12 | Takeda Pharmaceutical Company Limited | Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
JP2008019169A (ja) * | 2004-10-25 | 2008-01-31 | Osaka Univ | 新規ppar調節剤およびそのスクリーニング方法 |
CA2633149C (en) | 2005-12-22 | 2015-06-30 | Takeda Pharmaceutical Company Limited | Solid preparation containing an insulin sensitizer |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
JPS5697277A (en) * | 1980-01-07 | 1981-08-05 | Takeda Chem Ind Ltd | Thiazolidine derivative |
JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
US4582839A (en) * | 1984-03-21 | 1986-04-15 | Takeda Chemical Industries, Ltd. | 2,4-thiazolidinediones |
CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物,其制备方法和用途 |
JPH06779B2 (ja) * | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
US4812570A (en) * | 1986-07-24 | 1989-03-14 | Takeda Chemical Industries, Ltd. | Method for producing thiazolidinedione derivatives |
EP0842925A1 (en) * | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
US4791125A (en) * | 1987-12-02 | 1988-12-13 | Pfizer Inc. | Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents |
US5061717A (en) * | 1988-03-08 | 1991-10-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
MX15171A (es) * | 1988-03-08 | 1993-05-01 | Pfizer | Derivados de tiazolidinodiona hipoglicemicos |
WO1991007107A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
JPH04210683A (ja) * | 1990-12-06 | 1992-07-31 | Terumo Corp | チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬 |
US5183823A (en) * | 1991-04-11 | 1993-02-02 | Takeda Chemical Industries, Ltd. | Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents |
ES2089474T3 (es) * | 1991-08-16 | 1996-10-01 | Sandoz Ltd | Inhalador para la administracion de sustancias en polvo. |
AU2479492A (en) * | 1991-08-26 | 1993-03-16 | Upjohn Company, The | Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride |
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
US5859037A (en) * | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
-
1997
- 1997-07-18 GB GB9715306A patent/GB9715306D0/en active Pending
-
1998
- 1998-07-15 DZ DZ980174A patent/DZ2564A1/xx active
- 1998-07-16 MA MA25173A patent/MA26522A1/fr unknown
- 1998-07-16 WO PCT/GB1998/002109 patent/WO1999003476A1/en active IP Right Grant
- 1998-07-16 AP APAP/P/2000/001734A patent/AP1318A/en active
- 1998-07-16 SI SI9830892T patent/SI0998291T2/sl unknown
- 1998-07-16 CN CN98807221A patent/CN1264302A/zh active Pending
- 1998-07-16 PT PT98935126T patent/PT998291E/pt unknown
- 1998-07-16 KR KR1020007000513A patent/KR100680667B1/ko not_active IP Right Cessation
- 1998-07-16 OA OA1200000014A patent/OA11632A/en unknown
- 1998-07-16 SK SK60-2000A patent/SK287823B6/sk not_active IP Right Cessation
- 1998-07-16 PE PE1998000631A patent/PE99799A1/es not_active Application Discontinuation
- 1998-07-16 JP JP2000502775A patent/JP2001510158A/ja not_active Withdrawn
- 1998-07-16 DK DK98935126.7T patent/DK0998291T4/da active
- 1998-07-16 EP EP98935126A patent/EP0998291B2/en not_active Expired - Lifetime
- 1998-07-16 UA UA2000010215A patent/UA70302C2/uk unknown
- 1998-07-16 PL PL375989A patent/PL199125B1/pl unknown
- 1998-07-16 AT AT98935126T patent/ATE366577T1/de active
- 1998-07-16 AU AU84487/98A patent/AU743269B2/en not_active Expired
- 1998-07-16 HU HU0003634A patent/HU229119B1/hu unknown
- 1998-07-16 NZ NZ520652A patent/NZ520652A/en not_active IP Right Cessation
- 1998-07-16 TR TR2000/00135T patent/TR200000135T2/tr unknown
- 1998-07-16 PL PL98338127A patent/PL338127A1/xx not_active Application Discontinuation
- 1998-07-16 CZ CZ20000173A patent/CZ302668B6/cs not_active IP Right Cessation
- 1998-07-16 EA EA200000141A patent/EA003303B1/ru not_active IP Right Cessation
- 1998-07-16 NZ NZ515555A patent/NZ515555A/xx not_active IP Right Cessation
- 1998-07-16 CA CA2297115A patent/CA2297115C/en not_active Expired - Lifetime
- 1998-07-16 IL IL13404598A patent/IL134045A0/xx unknown
- 1998-07-16 NZ NZ501256A patent/NZ501256A/xx not_active IP Right Cessation
- 1998-07-16 DE DE69838066T patent/DE69838066T3/de not_active Expired - Lifetime
- 1998-07-16 ID IDW20000074A patent/ID24198A/id unknown
- 1998-07-16 BR BR9810904-9A patent/BR9810904A/pt not_active Application Discontinuation
- 1998-07-16 ES ES98935126T patent/ES2290989T5/es not_active Expired - Lifetime
- 1998-07-16 SK SK89-2005A patent/SK288053B6/sk not_active IP Right Cessation
- 1998-07-17 ZA ZA9806365A patent/ZA986365B/xx unknown
- 1998-07-17 UY UY25103A patent/UY25103A1/es not_active IP Right Cessation
- 1998-07-17 MY MYPI98003290A patent/MY138246A/en unknown
- 1998-07-17 TW TW087111768A patent/TW586926B/zh not_active IP Right Cessation
- 1998-07-17 AR ARP980103516A patent/AR016768A1/es not_active Application Discontinuation
- 1998-07-17 CO CO98040748A patent/CO4940422A1/es unknown
- 1998-07-20 IN IN2089DE1998 patent/IN189035B/en unknown
-
1999
- 1999-06-18 AR ARP990102953A patent/AR019331A2/es unknown
-
2000
- 2000-01-17 NO NO20000229A patent/NO326356B1/no not_active IP Right Cessation
- 2000-02-08 BG BG104139A patent/BG64892B1/bg active Active
- 2000-10-24 HK HK00106765A patent/HK1029272A1/xx not_active IP Right Cessation
-
2005
- 2005-04-21 JP JP2005123586A patent/JP2005247865A/ja active Pending
-
2007
- 2007-09-27 CY CY20071101241T patent/CY1107745T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105254T1 (el) | Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο | |
BG95935A (bg) | Метод и средство за приемане на дексмедетомидин директно през кожата | |
NO20090846L (no) | Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav | |
TR200100600T2 (tr) | İnsülinotropik peptitlerin kullanımı. | |
NO940436L (no) | Forlenget avgivelse av peptider | |
DE69327309T2 (de) | Verwendung eines peptids | |
YU37301A (sh) | Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa | |
TR200000135T2 (tr) | Tiazolidinedion ve sülfonilüre ile diabet tedavisi. | |
TR200503846T2 (tr) | Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı | |
TR200000133T2 (tr) | Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi. | |
DE69630527D1 (de) | Vorbeugung einer krankheit mit diabetes charakter | |
TR199903096T2 (tr) | Diabetin tiazolidinedion ve sülfonilüre ile tedavisi. | |
TR200101336T2 (tr) | Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar | |
NO996270L (no) | Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor | |
IL143088A0 (en) | A method for the treatment of type 2 diabetes mellitus and conditions associated therewith, and a pharmaceutical composition comprising an insulin sensitiser for use in such a method | |
TR200000958T2 (tr) | Hiperglisemi tedavisinde tiazolidinedion kullanımı. | |
HUP0002669A2 (hu) | Diabetes kezelése dioxo-tiazolidinnel és szulfonil-karbamiddal | |
ECSP982534A (es) | Nuevo metodo de tratamiento | |
ECSP982593A (es) | Nuevo metodo de tratamiento vi | |
NO883237D0 (no) | Tilstrammings- og laasanordning for snorer, remmer el.l. | |
AP1692A (en) | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent. | |
IT8822360A0 (it) | Procedimento e dispositivo di misura dell'anticipo di inizio mandata dell'iniezione, particolarmente in motori diesel |